Vitamin D Testing Market

Vitamin D Testing Market Size

Vitamin D Testing Market size was USD 0.65 billion in 2021 and projected to grow from USD 0.7 billion in 2023 to USD 1.2 billion by 2032, exhibiting a CAGR of 5.5% during the forecast period.

Vitamin D Test measures the vitamin D level in a human blood to ensure he has sufficient for his body to perform well. Vitamin D is very important for both, healthy teeth and bones. It also aids to keep human nerves, muscles, and immune system function normally. Low vitamin D levels is a common issue that causes bone illnesses and other medical issues. Vitamin D testing showcases a patient’s vitamin D levels.

Market Highlights

Vitamin D Testing Market is expected to project a CAGR of 5.5% during the forecast period, 2022-2032

Vitamin D Testing Market is expected to reach USD 1.2 billion, growing at a CAGR of 5.5% during the forecast period owing to the growing regarding the impacts of nutritional deficiencies, increasing cases of chronic diseases in both old and young populations, and increasing geriatric population. The prevalence of vitamin D deficiency is expanding, and its significance is becoming more recognized, which has led to the rise in screening for the levels of Vitamin D serum, thus boosting the Vitamin D Testing Market.

Vitamin D Testing Market Segmentation

25-Hydroxy Vitamin D Test segment is expected to dominate in the forecast period

Vitamin D Testing Market is classified based on the Test Type into 25-Hydroxy Vitamin D Test and 1,25-Dihydroxy Vitamin D Test. The 25-hydroxy vitamin D category held a major share of the Vitamin D Testing Market in 2021 and is projected to lead over the forecast period. This is since tests are being conducted more often around the world, and it is simple to identify and guess the amounts of 25-hydroxyvitamin D in plasma serum despite its lower concentration and longer half-life. Furthermore, the segment is also driven by the capacity of the test to detect a variety of bone problems brought on by insufficient vitamin D levels.

Rickets segment is expected to dominate in the forecast period

Vitamin D Testing Market is classified based on the Indication into Osteoporosis, Rickets, Thyroid Disorders, Vitamin D Deficiency, and Others. Osteoporosis indication category held a major market share in 2022. This is owing to the growing cases of osteoporosis associated with vitamin D. Over the forecast period, the rickets indication category is anticipated to have profitable growth. The segment's growth is supported by the rising rickets among the population due to chronic vitamin D insufficiency.

Market Dynamics                                       

Growth Drivers

Growing Cases of Multiple Diseases and Increasing Geriatric Population is Expected to Boost the Market Growth

The Vitamin D Testing Market is expanding owing to the factors like the rising prevalence of rickets, osteoporosis, vitamin D deficiency, and thyroid diseases. Furthermore, rising awareness of various ailments, the necessity for testing to overcome illnesses, and the increasing senior population are all driving the growth. In addition, the COVID-19 pandemic forced public to stay at homes as a precaution. This led to the rising prevalence of insufficiency among the population throughout the pandemic, resulting in market growth with increased testing when the lockdowns and regulations were lifted.

Focus on Innovative Medications by Industry Players and Increasing demand for Home Test Kits are Expected to Boost the Market Growth

Market participants are emphasizing their efforts on the development of innovative medications for treating of associated illness conditions. Moreover, the rising demand and the introduction of home test kits are driving the Vitamin D Testing Market. The growing number of studies on the significance of vitamin D in various therapeutic contexts, and the rise in testing, are fuelling the market growth.

Restraint

Overuse of Vitamin D Testing in the Developed Nations   May Restrain the Market Growth

Vitamin D deficiency is among the essential elements associated to an individual's overall health. However, there has been a significant increase in repetitious testing in industrialized countries such as the United States, Germany, and others. This results in an overuse of healthcare resources like reagents, test kits, and others, which increases healthcare burdens over time.

Recent Developments

• F. Hoffmann-La Roche Ltd., in January 2022, launched Cobas Infinity Edge a cloud platform for managing and integrating point-of-care (POC) information available for application in clinical settings on the global scale.
• Empower Clinics Inc. developed the Vitamin D Rapid Testing Kit classified as the Medisure product in April 2022 to meet the growing demand for vitamin D tests in Canada.
• To accelerate growth, OmegaQuant introduced a vitamin D test that had a sample collection kit in 2020, allowing testing for deficiency from home.

Vitamin D Testing Market

Key Players Covered:

• Thermo Fisher Scientific Inc.
• Abbott
• Siemens Healthineers AG
• Roche Diagnostics USA
• Quest Diagnostics Incorporated
• BIOMÉRIEUX
• Beckman Coulter Inc.
• Tosoh Bioscience Inc.
• Quidel Corporation
• DiaSorin S.p.A.
• Everly Health
• DiaSys Diagnostic Systems GmbH
• Qualigen Therapeutics Inc.
• OmegaQuant
• Biohit Healthcare
• Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Regional Analysis

Vitamin D Testing Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America will lead the Market in 2022 owing to the introduction of novel products and growing need for technical improvements that streamline the testing process and deliver the results much faster. Asia-Pacific is predicted to develop at the fastest rate throughout the projection period due to increased awareness by the private entities and the government.

Impact of Covid-19 on Vitamin D Testing Market

COVID-19 had a positive impact on the market. A major population became more cautious due to the Covid-19 outbreak. Since a large population began undergoing whole body and blood checks, the Vitamin D Testing sector has grown. Along with the COVID-19 Pandemic's lockdown and other concerns, people grew more concerned about health, which contributed significantly to the pandemic's favorable market growth.

Vitamin D Testing Market is further segmented by region into:

• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA

Vitamin D Testing Market Scope and Segments

Frequently Asked Questions (FAQ):